4.8 Article

Multiple early factors anticipate post-acute COVID-19 sequelae

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19

Jihoon W. Lee et al.

Summary: The study reveals metabolic changes in immune cells of COVID-19 patients, with increasing disease severity correlating with monocytes bifurcating into two distinct metabolic subsets. The integrated analysis shows a strong interplay between plasma metabolites and cell-type-specific metabolic reprogramming networks associated with disease severity and potential survival prediction.

NATURE BIOTECHNOLOGY (2022)

Review Cardiac & Cardiovascular Systems

Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection A State-of-the-Art Review

David H. Jiang et al.

Summary: Most severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients survive the immediate infection, but are at risk for persistent and delayed multisystem complications. Postacute sequelae of SARS-CoV-2 infection (PASC) affect a significant portion of coronavirus disease 2019 survivors, with a wide range of symptoms and complications. Data on PASC risk factors and vulnerable populations are limited, but evidence suggests a disproportionate impact on certain groups.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Article Biochemistry & Molecular Biology

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Aurelien Sokal et al.

Summary: Memory B cells play a crucial role in host defense against SARS-CoV-2, with distinct B cell clone responses to the virus contributing to long-lasting immune protection. The study also highlights the significance of somatic mutations in the variable region genes of memory B cells over time, indicating continued maturation and long-term immune memory post-infection.
Article Biochemistry & Molecular Biology

COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

Xianwen Ren et al.

Summary: The study revealed the presence of immune response dysfunction in COVID-19 patients, with different peripheral immune subtype changes associated with clinical features such as age, sex, severity, and disease stages. Additionally, dramatic transcriptomic changes were observed within virus-infected cells, and upregulation of S100A8/A9 in peripheral blood may contribute to the cytokine storms frequently observed in severe patients.
Letter Medicine, General & Internal

Sequelae in Adults at 6 Months After COVID-19 Infection

Jennifer K. Logue et al.

JAMA NETWORK OPEN (2021)

Article Medicine, General & Internal

Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19

Maxime Taquet et al.

Summary: This study investigated the incidence and co-occurrence of long-COVID features in COVID-19 survivors, with comparisons to influenza patients, using electronic health records data. The findings showed that long-COVID clinical features were more commonly reported after COVID-19 infection, and differences were associated with sex, age, and illness severity.

PLOS MEDICINE (2021)

Article Immunology

Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses

Hong Zheng et al.

Summary: Viral infections trigger a distinct host response, with severe infections associated with increased hematopoiesis, myelopoiesis, and myeloid-derived suppressor cells. Protective and detrimental gene modules were identified to define different trajectories of outcomes, providing insights for the development of diagnostics and host-directed therapies to improve global pandemic preparedness.

IMMUNITY (2021)

Review Medicine, General & Internal

Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection A Systematic Review

Destin Groff et al.

Summary: This systematic review found that more than half of COVID-19 survivors experienced PASC 6 months after recovery, with the most common effects being functional mobility impairments, pulmonary abnormalities, and mental health disorders.

JAMA NETWORK OPEN (2021)

Article Multidisciplinary Sciences

Diverse functional autoantibodies in patients with COVID-19

Eric Y. Wang et al.

Summary: COVID-19 patients show increased autoantibody reactivities against immunomodulatory proteins, which may affect immune function and lead to different clinical outcomes.

NATURE (2021)

Article Biochemistry & Molecular Biology

Single-cell multi-omics analysis of the immune response in COVID-19

Emily Stephenson et al.

Summary: Transcriptomic and proteomic profiling of blood samples from individuals with COVID-19 reveals immune cell and hematopoietic progenitor cell alterations that are differentially associated with disease severity.

NATURE MEDICINE (2021)

Review Biochemistry & Molecular Biology

Post-acute COVID-19 syndrome

Ani Nalbandian et al.

Summary: SARS-CoV-2 is responsible for the COVID-19 pandemic, causing global healthcare crises. Recovery from COVID-19 may lead to persistent symptoms and long-term complications, prompting the need for multidisciplinary care and follow-up for survivors.

NATURE MEDICINE (2021)

Review Microbiology

Antibody and B cell responses to SARS-CoV-2 infection and vaccination

Katharina Roltgen et al.

Summary: Human immune responses to SARS-CoV-2 have made significant progress in understanding the nature of antibody responses and their role in protecting against infection or modulating the severity of COVID-19, aiding in the development of effective vaccines. However, important questions remain unanswered regarding the duration and effectiveness of antibody responses, immunity differences between infection and vaccination, cellular basis for serological findings, and the potential impact of viral variants on current immunity.

CELL HOST & MICROBE (2021)

Article Biochemistry & Molecular Biology

Long COVID in a prospective cohort of home-isolated patients

Bjorn Blomberg et al.

Summary: An analysis of patients with SARS-CoV-2 infections in Bergen, Norway, revealed that a high proportion of patients experienced long-term COVID symptoms at 6 months, even though they were relatively young and had only mild to moderate acute COVID-19 symptoms. This highlights the significance of infection control measures, such as vaccination.

NATURE MEDICINE (2021)

Article Multidisciplinary Sciences

New-onset IgG autoantibodies in hospitalized patients with COVID-19

Sarah Esther Chang et al.

Summary: In hospitalized COVID-19 patients, approximately 50% have detectable autoantibodies primarily targeting autoantigens associated with rare disorders. Additionally, a subset of autoantibodies develop de novo following SARS-CoV-2 infection.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care

Clemens Gutmann et al.

Summary: Prognostic characteristics for ICU COVID-19 patients can be determined using blood samples, with RNAemia and pentraxin-3 identified as predictors of 28-day ICU mortality. Additionally, galectin-3-binding protein is found to interact with the SARS-CoV-2 spike glycoprotein and exhibit antiviral properties.

NATURE COMMUNICATIONS (2021)

Review Microbiology

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms

Amy D. Proal et al.

Summary: The novel coronavirus SARS-CoV-2 has led to a pandemic of COVID-19, with some patients developing persistent symptoms known as Long COVID or PASC. These patients may have different underlying biological factors driving their symptoms, such as organ damage, persistent viral reservoirs, re-activation of pathogens, and immune dysregulation. Therapeutic approaches may need to be individualized to effectively manage care for specific patients with PASC.

FRONTIERS IN MICROBIOLOGY (2021)

Review Immunology

Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19

Rakhee K. Ramakrishnan et al.

Summary: COVID-19 has been present for over a year with limited treatment options available. Some recovered patients experience lingering symptoms, known as long COVID-19, possibly due to a persistent immune response causing ongoing inflammation processes.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Autoantibodies neutralizing type I IFNs are present in ∼4% of uninfected individuals over 70 years old and account for ∼20% of COVID-19 deaths

Paul Bastard et al.

Summary: Autoantibodies neutralizing interferons are present in a significant percentage of critical COVID-19 patients, especially in older individuals, and their prevalence increases with age.

SCIENCE IMMUNOLOGY (2021)

Article Microbiology

Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation

Jeffrey E. Gold et al.

Summary: The study found a prevalence of 30.3% for long COVID symptoms among COVID-19 patients, with some initially asymptomatic patients developing long-term symptoms. Additionally, a significantly higher rate of EBV reactivation was observed in long COVID subjects compared to control subjects, suggesting a potential association between COVID-19 inflammation and EBV reactivation.

PATHOGENS (2021)

Article Endocrinology & Metabolism

Long COVID: An overview

A. V. Raveendran et al.

Summary: Long COVID refers to the persistence of symptoms in individuals who have recovered from SARS-CoV-2 infection, possibly related to organ damage, post viral syndrome, etc. Clinical evaluation should focus on identifying the pathophysiology and appropriate remedial measures.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)

Article Biochemistry & Molecular Biology

Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development

Miao-Miao Zhao et al.

Summary: CTSL plays a crucial role in COVID-19 patients, with its levels positively correlated with disease severity. Research showed that CTSL promotes SARS-CoV-2 virus entry into cells, and the CTSL inhibitor amantadine can inhibit this process, providing a direction for the development of new anti-COVID-19 drugs.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Medicine, General & Internal

Systemic lupus erythematosus manifestation following COVID-19: a case report

Batool Zamani et al.

Summary: This is the first reported case of SLE manifestation following COVID-19. The patient received steroid treatment and exhibited relevant clinical features during follow-up.

JOURNAL OF MEDICAL CASE REPORTS (2021)

Article Biochemistry & Molecular Biology

VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium

Dmitry Bagaev et al.

NUCLEIC ACIDS RESEARCH (2020)

Review Medicine, Research & Experimental

Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases

Lien D. Nguyen et al.

EMBO MOLECULAR MEDICINE (2020)

Letter Medicine, General & Internal

Early Detection of Covid-19 through a Citywide Pandemic Surveillance Platform

Helen Y. Chu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemical Research Methods

Scirpy: a Scanpy extension for analyzing single-cell T-cell receptor-sequencing data

Gregor Sturm et al.

BIOINFORMATICS (2020)

Article Biochemistry & Molecular Biology

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Jonas Schulte-Schrepping et al.

Letter Immunology

Expansion of atypical memory B cells is a prominent feature of COVID-19

Barbara Oliviero et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Editorial Material Rheumatology

Autoimmune and inflammatory diseases following COVID-19

Caroline Galeotti et al.

NATURE REVIEWS RHEUMATOLOGY (2020)

Review Rheumatology

New insights into the role of antinuclear antibodies in systemic lupus erythematosus

David S. Pisetsky et al.

NATURE REVIEWS RHEUMATOLOGY (2020)

Article Biochemistry & Molecular Biology

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Yapeng Su et al.

Review Medicine, General & Internal

Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease

Alison W. Rebman et al.

FRONTIERS IN MEDICINE (2020)

Article Biochemistry & Molecular Biology

Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data

Samuel L. Wolock et al.

CELL SYSTEMS (2019)

Review Biochemistry & Molecular Biology

Dual-Specificity Phosphatases in Immunity and Infection: An Update

Roland Lang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemistry & Molecular Biology

T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant

Aude G. Chapuis et al.

NATURE MEDICINE (2019)

Review Respiratory System

Approaches to Addressing Post-Intensive Care Syndrome among Intensive Care Unit Survivors A Narrative Review

Samuel M. Brown et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2019)

Article Multidisciplinary Sciences

From Louvain to Leiden: guaranteeing well-connected communities

V. A. Traag et al.

SCIENTIFIC REPORTS (2019)

Article Cell Biology

A Multi-omic Association Study of Trimethylamine N-Oxide

Ohad Manor et al.

CELL REPORTS (2018)

Review Immunology

Bystander T Cells: A Balancing Act of Friends and Foes

Sarah K. Whiteside et al.

TRENDS IN IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

JunB regulates homeostasis and suppressive functions of effector regulatory T cells

Shin-ichi Koizumi et al.

NATURE COMMUNICATIONS (2018)

Article Biotechnology & Applied Microbiology

SCANPY: large-scale single-cell gene expression data analysis

F. Alexander Wolf et al.

GENOME BIOLOGY (2018)

Review Pediatrics

Recovery of steroid induced adrenal insufficiency

Areej K. Younes et al.

TRANSLATIONAL PEDIATRICS (2017)

Review Medicine, General & Internal

Adrenal Crisis: Still a Deadly Event in the 21st Century

Troy H. K. Puar et al.

AMERICAN JOURNAL OF MEDICINE (2016)

Article Rheumatology

Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity

Samantha Slight-Webb et al.

ARTHRITIS & RHEUMATOLOGY (2016)

Article Allergy

The 3 major types of innate and adaptive cell-mediated effector immunity

Francesco Annunziato et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

Article Biochemistry & Molecular Biology

IgBLAST: an immunoglobulin variable domain sequence analysis tool

Jian Ye et al.

NUCLEIC ACIDS RESEARCH (2013)

Article Multidisciplinary Sciences

Using synthetic templates to design an unbiased multiplex PCR assay

Christopher S. Carlson et al.

NATURE COMMUNICATIONS (2013)

Editorial Material Rheumatology

Antinuclear antibodies in healthy people: the tip of autoimmunity's iceberg?

David S. Pisetsky

ARTHRITIS RESEARCH & THERAPY (2011)

Article Immunology

IFN-α/β enhances BCR-dependent B cell responses

D Braun et al.

INTERNATIONAL IMMUNOLOGY (2002)

Review Immunology

Effector and memory T-cell differentiation: Implications for vaccine development

SM Kaech et al.

NATURE REVIEWS IMMUNOLOGY (2002)